Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001759910-26-000004

Chief Financial Officer acquired 116,144 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hearne Michael S · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-18 Grant or award : show line 1 in the form +116,144 116,144 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-18 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +70,230 70,230 D
Loading xslF345X06/wk-form4_1779311085.xml…